All Updates

All Updates

icon
Filter
Funding
Genialis raises USD 13 million in Series A funding
Precision Medicine
Mar 29, 2023
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Mar 29, 2023

Genialis raises USD 13 million in Series A funding

Funding

  • Genialis, a computational bioinformatics company, has raised more than USD 13 million in a Series A funding round led by Taiwania Capital and Debiopharm Innovation Fund, with participation from P5 Health Ventures and existing investors. This brings total funds raised to USD 15.5 million. 

  • The funds will be used to expand the company’s ResponderID platform, develop next-generation patient classifiers using machine learning and high-throughput omics data, and build out clinically validated biomarker models to provide pinpoint diagnoses for cancer patients. The funds will also be used to grow its teams in the US and Slovenia.

  • Genialis is a computational precision medicine company that uses its machine-learning-driven ResponderID platform to provide biomarkers for disease modeling, drug development, and clinical care. The company has collaborated with biopharma to analyze clinical trial data and inform future trial designs for investigational drugs, and supports the commercialization of next-gen biomarker assays with leading diagnostic firms. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.